Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-label, Single-arm, Two-step Study to Evaluate the Safety and Single-dose Pharmacokinetics of Famciclovir and Multiple-dose Safety After Administration of Famciclovir Oral Pediatric Formulation to Children 1 to 12 Years of Age With Herpes Simplex Infection
Conditions
Interventions
Famciclovir
Locations
13
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
The Children's Hospital
Denver, Colorado, United States
Children's Memorial Hospital
Chicago, Illinois, United States
Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky, United States
Columbia University Medical Center
New York, New York, United States
State University of New York at
Stony Brook, New York, United States
Start Date
February 1, 2005
Primary Completion Date
December 1, 2007
Completion Date
December 1, 2007
Last Updated
April 25, 2013
NCT04065971
NCT05429346
NCT03282916
NCT05226949
NCT03626376
NCT00000635
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions